Morgan Stanley Maintains NVIDIA Overweight/Top Pick, Raises Target Price to $288

Overview

This is an earnings review report on NVIDIA CORP by Morgan Stanley. The report notes that NVIDIA's latest quarterly results delivered a "clean beat and raise," with revenue, EPS, and guidance all above expectations, and Vera Rubin progressing on schedule, helping address market concerns about competition from ASICs, TPUs, and other rivals. The analyst maintains an Overweight/Top Pick rating and raises the target price from $285 to $288.

Core views

The core view is that NVIDIA remains the most important supplier of AI chips, and its advantages in AI factory economics and cost per token have not yet been disproven by lower-cost silicon alternatives. Although the market worries about share loss, index weighting, and high expectations suppressing the stock's reaction, the report argues that the current valuation is below next year's 17x and roughly half that of AI peers, leaving risk/reward compelling. If Vera Rubin is delivered on schedule, it should help investors shift from comparing NVIDIA's current products against competitors' next-generation products to a more appropriate generational comparison.

Analysis framework

The report combines actual reported results, company guidance, Morgan Stanley ModelWare forecasts, relative valuation, and risk/reward scenario analysis. The target price methodology is unchanged, using about 22x CY27 ModelWare EPS estimate, corresponding to FY28 earnings power; it also evaluates upside and downside through bull/bear base scenarios, option-implied probabilities, consensus target-price distributions, and key operating drivers.

Methodology notes

• Earnings ForecastMorgan Stanley ModelWare

  ModelWare-based revenue, gross margin, and EPS forecasts

  The report states that, unless otherwise noted, the main metrics are based on the Morgan Stanley ModelWare framework, and FY27 and FY28 revenue and non-GAAP EPS forecasts are raised accordingly.

• Valuation methodsP/E multiple valuation

  About 22x CY27 EPS valuation

  The $288 target price is based on about 22x Morgan Stanley CY27 EPS estimate of $13.08; this multiple is roughly in line with the broader market and below compute semiconductor peers such as AMD, AVGO, and INTC.

• Risk/RewardRisk Reward framework

  Bull/bear/base scenarios and 12-month option-implied probability

  The report uses a risk/reward chart, target-price distribution, and scenario analysis to assess the potential price paths associated with the $160 bear case, $288 base target price, and $330 bull case.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• NVIDIA CORP (NVDA.US)

  Company covered and core recommended name in the report

  Strengths

  Strong AI chip supply position, robust data center growth, Vera Rubin progressing on schedule, and purchase commitments plus gross margin guidance supporting near- to medium-term revenue visibility.

  Weaknesses

  Market share estimation is complex, and the current high market share and high gross margin limit short-term valuation multiple expansion; index weighting may also be a funding allocation headwind.

  Comparison

  Valuation is about 22x CY27 EPS, close to the broader market and at a discount versus compute semiconductor peers such as AMD, AVGO, and INTC; the report believes the valuation gap versus AI peers is too wide.

  Risks

  Slower data center growth, challenges from ASICs/TPUs/AMD and other peers, customer in-house hardware, tariffs and export controls, and a cooling in the AI capex cycle.

• Semiconductors

  Industry and investment backdrop

  Strengths

  Demand for AI training and inference is driving cloud capex growth, and next-generation GPU and networking products may continue to expand the market opportunity.

  Weaknesses

  Industry supply constraints, competitive product cycles, and valuation dispersion make share and earnings durability harder to assess.

  Comparison

  NVIDIA is viewed as the most critical company in the AI chip supply chain and still has an earnings momentum advantage versus compute semiconductor peers.

  Risks

  Lower AI development costs, mature substitute chips, export restrictions, and macro capex contraction could weaken industry growth.

Key data

• April quarter revenue$81.615bnUp 95.1% year over year and 19.8% quarter over quarter, above market expectations of $78.907bn and Morgan Stanley expectations of $79.264bn.
• Data Center revenue$75.249bnUp 92.4% year over year and 20.8% quarter over quarter, still the core source of growth.
• Non-GAAP EPS$1.87Above market expectations of $1.75 and Morgan Stanley expectations of $1.72.
• July quarter revenue guidance$91bnThe midpoint is about $10bn higher quarter over quarter, above market expectations of $87.293bn and Morgan Stanley expectations of $87.880bn.
• Gross margin guidance75.0%Above market expectations of 74.5%, viewed as positive amid rising component prices.
• Purchase commitments$119bnUp nearly $30bn from the prior quarter, with $95bn expected to be used for production over the next three quarters, helping ease concerns about supply constraints.
• FY27 forecastRevenue $393.005bn, non-GAAP EPS $8.98Revenue growth forecast raised to 82.0% y/y.
• FY28 forecastRevenue $598.809bn, non-GAAP EPS $13.15Revenue growth forecast at 52.4% y/y.
• Target price$288.00Raised from the prior $285.00, based on an estimate of about 22x CY27 EPS.

Impact & implications

The investment implication for NVIDIA is positive: the earnings beat and guidance raise reinforce the view that the AI capex cycle is still expanding, and Vera Rubin's on-schedule progress should help extend NVIDIA's leadership in performance and system economics. If the market continues to underestimate its relative valuation and earnings revision potential, the stock may have further rerating upside; however, if data center growth slows or customer in-house chips accelerate substitution, the investment case will face challenges.

Risks

• Data center revenue growth may slow materially once supply catches up with demand.
• If AI development costs fall sharply or stronger competitors enter the market, NVIDIA's share could be eroded.
• Customers may increase the use of in-house custom hardware, reducing reliance on NVIDIA GPUs and systems.
• Tariffs and export controls could create greater-than-expected pressure on revenue and profits.
• Market concerns about NVIDIA share loss may take time to digest, so valuation rerating may not happen immediately.

What to watch

• Vera Rubin delivery in 3Q and subsequent ramp-up progress.
• Whether the $91bn July quarter revenue guidance is achieved and the quality of data center growth.
• Whether gross margin can stay around 75%, especially in the context of rising component prices.
• The pace at which the $119bn purchase commitments convert into revenue, and the use of the $95bn production commitment over the next three quarters.
• Cost per token performance of AMD MI455, TPU v8, ASICs, and customer in-house chips relative to NVIDIA's platform.
• Recovery in China revenue, export control developments, and tariff policy changes.